Literature DB >> 28159734

Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis.

Chetasi Talati1,2, Ling Zhang1, Ghada Shaheen1, Andrew Kuykendall1,2, Markus Ball1, Qing Zhang1, Jeffrey E Lancet1, Kenneth S Zuckerman1, Alan F List1, Rami Komrokji1, Lynn Moscinski1, Eric Padron1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28159734     DOI： 10.1182/blood-2016-12-753210

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

Review 1.  Laboratory Evaluation and Pathological Workup of Neoplastic Monocytosis - Chronic Myelomonocytic Leukemia and Beyond.

Authors:  Siba El Hussein; Joseph D Khoury; L Jeffrey Medeiros; Sanam Loghavi
Journal:  Curr Hematol Malig Rep       Date:  2021-05-04       Impact factor: 3.952

Review 2.  Chronic myelomonocytic leukemia diagnosis and management.

Authors:  Onyee Chan; Aline Renneville; Eric Padron
Journal:  Leukemia       Date:  2021-03-13       Impact factor: 11.528

Review 3.  Recent Updates on Chronic Myelomonocytic Leukemia.

Authors:  Sanam Loghavi; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 4.  Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors:  Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-06       Impact factor: 10.047

Review 5.  Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.

Authors:  Giacomo Coltro; Mrinal M Patnaik
Journal:  Curr Oncol Rep       Date:  2019-11-14       Impact factor: 5.075

6.  A medical mirroring: chronic myelomonocytic leukemia mimicking immunoglobulin G4-related disease.

Authors:  Zhiqian Bai; Yuxue Chen; Xiaoqi Chen; Lingli Dong
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 7.  Chronic Myelomonocytic Leukemia: Hematopathology Perspective.

Authors:  Siba El Hussein; Sa A Wang; Naveen Pemmaraju; Joseph D Khoury; Sanam Loghavi
Journal:  J Immunother Precis Oncol       Date:  2021-06-18

8.  Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.

Authors:  Xavier Calvo; Nieves Garcia-Gisbert; Ivonne Parraga; Joan Gibert; Lourdes Florensa; Marcio Andrade-Campos; Brayan Merchan; Sara Garcia-Avila; Sara Montesdeoca; Concepción Fernández-Rodríguez; Marta Salido; Anna Puiggros; Blanca Espinet; Luís Colomo; David Roman-Bravo; Beatriz Bellosillo; Ana Ferrer; Leonor Arenillas
Journal:  Blood Adv       Date:  2020-10-27

Review 9.  Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.

Authors:  Rory M Shallis; Alexa J Siddon; Amer M Zeidan
Journal:  Curr Hematol Malig Rep       Date:  2021-04-22       Impact factor: 3.952

10.  How I diagnose and treat chronic myelomonocytic leukemia.

Authors:  Mrinal M Patnaik
Journal:  Haematologica       Date:  2022-07-01       Impact factor: 11.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.